Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson’s disease
Open accessAbstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive loss of the dopaminergic neurons of the substantia nigra pars compacta (SNpc). Although various treatments are successfully used to alleviate the symptoms of PD, none of them prevents or halts the neurodegenerative process of the disease. Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family of proteins, supports the survival and the differentiation of dopaminergic neurons. BDNF also prevents the death of dopaminergic neurons in vitro, which suggests that it may be of possible use in the development of neuroprotective therapies for PD. To determine whether BDNF is neuroprotective for SNpc dopaminergic neurons in the adult brain, we used a rat model of PD in which degeneration of 60-70% of these neurons was induced by an intrastriatal injection of 6-hydroxydopamine (6-OHDA). We report here that intrastriatal grafts of fibroblasts genetically engineered to produce BDNF partially prevent the loss of nerve terminals and completely prevent the loss of cell bodies of the nigrostriatal dopaminergic pathway that is induced by the intrastriatal injection of 6-OHDA. In contrast, the implantation of control fibroblasts that did not produce BDNF failed to protect nerve terminals and cell bodies against 6-OHDA-induced damage. Our observation that grafts of BDNF-producing fibroblasts protect against 6-OHDA-induced degeneration of SNpc dopaminergic neurons in the adult rat brain opens new perspectives for treatments aimed at the prevention of neurodegeneration in PD, using gene therapy and neurotrophic factors such as BDNF.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the vast majority of studies with BDNF administration before induction of parkinsonism, the results revealed at least partial prevention of neuronal cell loss.
“In the vast majority of studies with BDNF administration before induction of parkinsonism, the research results revealed at least partial prevention of neuronal cell loss [89,90,92,93,99,101].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
Estimation of nuclear population from microtome sections
Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363 · see citing works
Neurotransmitters and neuromodulators in the basal ganglia
Graybiel, A. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90104-i · Cited by 1,576 · see citing works
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494 · see citing works
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927 · see citing works
Gerfen, C. R., Herkenham, M. A., & Thibault, J. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-12-03915.1987 · Cited by 804 · see citing works
Neurotrophic factors: from molecule to man
Lindsay, R. M., Wiegand, S. J., Altar, C. A., & DiStefano, P. S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90099-x · Cited by 789 · see citing works
Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., & Barde, Y. (1992) · Nature · doi:10.1038/360757a0 · Cited by 706 · see citing works
Beck, K. D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R. A., Rosenthal, A., & Hefti, F. F. (1995) · Nature · doi:10.1038/373339a0 · Cited by 654 · see citing works
Knüsel, B., Winslow, J. W., Rosenthal, A., Burton, L. E., Seid, D. P., Nikolics, K., & Hefti, F. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.961 · Cited by 603 · see citing works
Neurotrophins and brain insults
Lindvall, O., Kokaia, Z., Bengzon, J., Elmér, E., & Kokaia, M. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90139-2 · Cited by 558 · see citing works
Przedborski, S., Kostić, V., Jackson-Lewis, V. R., Naini, A. B., Simonetti, S., Fahn, S., Carlson, E. J., Epstein, C. J., & Cadet, J. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01658.1992 · Cited by 456 · see citing works
Self-citationMolecular cloning of a human gene that is a member of the nerve growth factor family.
Jones, K. R., & Reichardt, L. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.8060 · Cited by 404 · see citing works
Knüsel, B., Beck, K., Winslow, J. W., Rosenthal, A., Burton, L., Widmer, H., Nikolics, K., & Hefti, F. F. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04391.1992 · Cited by 278 · see citing works
New insights into the cause of Parkinson's disease
Jenner, P., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Neurology · doi:10.1212/wnl.42.12.2241 · Cited by 272 · see citing works
Frim, D. M., Uhler, T. A., Galpern, W. R., Beal, M. F., Breakefield, X. O., & Isacson, O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5104 · Cited by 269 · see citing works
Morse, J., Wiegand, S., Anderson, K., You, Y., Cai, N., Carnahan, J., Miller, J., DiStefano, P., Altar, C., & Lindsay, R. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04146.1993 · Cited by 251 · see citing works
The neurotrophins and their receptors
Glass, D. J., & Yancopoulos, G. D. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90054-5 · Cited by 172 · see citing works
The Therapeutic Potential of Neurotrophic Factors in the Treatment of Parkinson's Disease
Lindsay, R. M., Altar, C. A., Cedarbaum, J. M., Hyman, C., & Wiegand, S. J. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1181 · Cited by 165 · see citing works
Lapchak, P. A., Beck, K. D., Araujo, D. M., Irwin, I., Langston, J. W., & Hefti, F. F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90612-j · Cited by 78 · see citing works
Du, X., Stull, N. D., & Iacovitti, L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00215-c · Cited by 70 · see citing works
Kawaja, M. D., & Gage, F. H. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903170108 · Cited by 53 · see citing works
Adverse Effects of Levodopa in Parkinson’s Disease
Fahn, S. (1989) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-73899-9_14 · Cited by 52 · see citing works
Pezzoli, G., Zecchinelli, A., Ricciardi, S., Burke, R. E., Fahn, S., Scarlato, G., & Carenzi, A. (1991) · Movement Disorders · doi:10.1002/mds.870060403 · Cited by 47 · see citing works
Przedborski, S., Levivier, M., Kostić, V., Jackson-Lewis, V. R., Dollison, A. M., Gash, D. M., Fahn, S., & Cadet, J. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)91323-s · Cited by 42 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Jackson-Lewis V, Jakowec M, Burke RE, Przedbroski S (1995) Time course and morphology of dopaminergic neuronal death caused by neurotoxin I-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurode- generation, in press.
Cited by
Sorted by citations
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947 · see citing works
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · see citing works
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Nagahara, A. H., & Tuszynski, M. H. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3366 · Cited by 867 · see citing works
The impact of age, weight and gender on BDNF levels in human platelets and plasma
Lommatzsch, M., Zingler, D., Schuhbaeck, K., Schloetcke, K., Zingler, C., Schuff‐Werner, P., & Virchow, J. C., Jr. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.002 · Cited by 849 · see citing works
Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease
Mattson, M. P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.005 · Cited by 640 · see citing works
BDNF mediates adaptive brain and body responses to energetic challenges
Marosi, K., & Mattson, M. P. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.10.006 · Cited by 568 · see citing works
Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Dunnett, S. B., & Björklund, A. (1999) · Nature · doi:10.1038/399a032 · Cited by 539 · see citing works
The role of neuronal growth factors in neurodegenerative disorders of the human brain
Connor, B. J., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 534 · see citing works
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504 · see citing works
Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra
Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513 · see citing works
Changes in cytokines and neurotrophins in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_19 · Cited by 507 · see citing works
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00463-2 · Cited by 394 · see citing works
Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation
Teismann, P., & Schulz, J. B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0944-0 · Cited by 363 · see citing works
Baquet, Z., Bickford, P., & Jones, K. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4601-04.2005 · Cited by 301 · see citing works
Scalzo, P., Kümmer, A., Bretas, T. L., Cardoso, F., & Teixeira, A. L. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5357-2 · Cited by 299 · see citing works
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
Alexi, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00032-5 · Cited by 290 · see citing works
Pathogenic role of glial cells in Parkinson's disease
Teismann, P., Tieu, K., Cohen, O. S., Choi, D., Wu, D. C., Marks, D., Vila, M., Jackson-Lewis, V. R., & Przedborski, S. (2002) · Movement Disorders · doi:10.1002/mds.10332 · Cited by 272 · see citing works
Self-citationTyrosine Hydroxylase and Parkinson’s Disease
Haavik, J., & Toska, K. (1998) · Molecular Neurobiology · doi:10.1007/bf02741387 · Cited by 263 · see citing works
Chang, J. W., Wachtel, S. R., Young, D., & Kang, U. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00217-6 · Cited by 248 · see citing works
Self-citationNeuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF
Cohen, A. D., Tillerson, J. L., Smith, A. D., Schallert, T., & Zigmond, M. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01657.x · Cited by 243 · see citing works
Marosi, K., Kim, S. W., Moehl, K., Scheibye‐Knudsen, M., Cheng, A., Cutler, R., Camandola, S., & Mattson, M. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13868 · Cited by 242 · see citing works
Human neural stem cells genetically modified for brain repair in neurological disorders
Kim, S. (2004) · Neuropathology (Kyoto. 1993) · doi:10.1111/j.1440-1789.2004.00552.x · Cited by 225 · see citing works
Kramer, E. R., Aron, L., Ramakers, G. M. J., Sabine, S., Zhuang, X., Beyer, K., Smidt, M. P., & Klein, R. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050039 · Cited by 210 · see citing works
Emerich, D. F., Lindner, M. D., Winn, S. R., Chen, E., Frydel, B. R., & Kordower, J. H. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-16-05168.1996 · Cited by 202 · see citing works
Role of MicroRNAs in Parkinson’s Disease
Goh, S. Y., Chao, Y., Dheen, S. T., Tan, E., & Tay, S. S. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225649 · Cited by 179 · see citing works
Tissue engineering: generation of differentiated artificial tissues for biomedical applications
Minuth, W. W., Sittinger, M., & Kloth, S. (1997) · Cell and Tissue Research · doi:10.1007/s004410050974 · Cited by 171 · see citing works
Teixeira, A. L., Barbosa, I. G., Diniz, B. S., & Kümmer, A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.111 · Cited by 162 · see citing works
Hu, Y., & Russek, S. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05237.x · Cited by 161 · see citing works
Neurotrophic factor therapy for Parkinson’s disease
Rangasamy, S. B., Soderstrom, K. E., Bakay, R. A. E., & Kordower, J. H. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84013-0 · Cited by 155 · see citing works
Sun, M., Kong, L., Wang, X., Lu, X.-G., Gao, Q., & Geller, A. I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.072 · Cited by 154 · see citing works
Berger, B., Grissac, N. D., & Alvarez, C. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990118)403:3 · Cited by 16 · see citing works
Costantini, L. C., Bakowska, J. C., Breakefield, X. O., & Ole Isacson, A. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301119 · Cited by 142 · see citing works
Brain-derived neurotrophic factor
Benarroch, E. E. (2015) · Neurology · doi:10.1212/wnl.0000000000001507 · Cited by 135 · see citing works
Porritt, M. J., Batchelor, P. E., & Howells, D. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.030 · Cited by 135 · see citing works
Brain-derived neurotrophic factor as a drug target for CNS disorders
Pezet, S., & Malcangio, M. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.391 · Cited by 132 · see citing works
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease
Fumagalli, F., Racagni, G., & Riva, M. A. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500360 · Cited by 132 · see citing works
Balaratnasingam, S., & Janča, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.006 · Cited by 131 · see citing works
Low BDNF is associated with cognitive impairments in patients with Parkinson’s disease
Wang, Y., Liu, H. S., Zhang, B., Soares, J. C., & Zhang, X. Y. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.023 · Cited by 129 · see citing works
Park, H., Lim, S., Joo, W. S., Yin, C.-S., Lee, H., Lee, H., Seo, J.-C., Leem, K., Son, Y.-S., Kim, Y.-J., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00031-6 · Cited by 129 · see citing works
Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer
Klein, R. L., Lewis, M. H., Muzyczka, N., & Meyer, E. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02116-2 · Cited by 128 · see citing works
Géral, C., Angelova, A., & Lesieur, S. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5010127 · Cited by 124 · see citing works
Zhu, G., Li, J., He, L., Wang, X., & Hong, X. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13061 · Cited by 118 · see citing works
Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor
Chen, M., Valenzuela, R. M., & Dhib-Jalbut, S. S. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00177-1 · Cited by 118 · see citing works
Bencsics, C. E., Wachtel, S. R., Milstien, S., Hatakeyama, K., Becker, J. B., & Kang, U. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04449.1996 · Cited by 109 · see citing works
Self-citationJollivet, C., Aubert‐Pouëssel, A., Clavreul, A., Venier‐Julienne, M., Remy, S., Montero‐Menei, C. N., Benoît, J., & Meneï, P. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00601-x · Cited by 103 · see citing works
Liang, X., Liu, X., Li, F.-Q., Luo, Y., Lü, J., Zhang, W.-M., Wang, X.-M., & Han, J.-S. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00513-2 · Cited by 105 · see citing works
Batchelor, P., Liberatore, G. T., Porritt, M. J., Donnan, G. A., & Howells, D. W. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00239.x · Cited by 105 · see citing works
Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
Hou, L., Chen, W., Liu, X., Qiao, D., & Zhou, F.-M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00358 · Cited by 105 · see citing works
McCoy, M. K., Martinez, T. N., Ruhn, K. A., Wrage, P. C., Keefer, E. W., Botterman, B. R., Tansey, K. E., & Tansey, M. G. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.011 · Cited by 104 · see citing works
Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro
Volpicelli, F., Caiazzo, M., Greco, D., Consales, C., Leone, L., Perrone‐Capano, C., D’Amato, L. C., & di Porzio, U. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04494.x · Cited by 100 · see citing works
Hagg, T. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6684 · Cited by 98 · see citing works
Experimental models of Parkinson's disease: insights from many models.
Tolwani, R. J., Jakowec, M. W., Petzinger, G. M., Green, S. L., & Waggie, K. S. (1999) · PubMed · Cited by 96 · see citing works
Lin, C., Lin, Y.-C., Huang, C.-Y., Wu, S.-R., Chen, C., & Liu, H.-L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.044 · Cited by 94 · see citing works
Loh, N. K., Woerly, S., Bunt, S. M., Wilton, S. D., & Harvey, A. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7692 · Cited by 91 · see citing works
Emerich, D. F., Cain, C. K., Greco, C., Saydoff, J. A., Hu, Z. Y., Liu, H., & Lindner, M. D. (1997) · Cell Transplantation · doi:10.1016/s0963-6897(97)00035-3 · Cited by 91 · see citing works
Therapeutic Potential of Nerve Growth Factors in Parkinson??s Disease
Collier, T. J., & Sortwell, C. E. (1999) · Drugs & Aging · doi:10.2165/00002512-199914040-00003 · Cited by 90 · see citing works
Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases
Levy, Y. S., Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2005) · BioDrugs · doi:10.2165/00063030-200519020-00003 · Cited by 90 · see citing works
Pathogenesis of Parkinson's Disease: Prospects of Neuroprotective and Restorative Therapies
Fernández‐Espejo, E. (2004) · Molecular Neurobiology · doi:10.1385/mn:29:1:15 · Cited by 88 · see citing works
Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis
Jiang, L., Zhang, H., Wang, C., Ming, F., Shi, X., & Yang, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.010 · Cited by 86 · see citing works
Zloković, B. V., & Apuzzo, M. L. J. (1997) · Neurosurgery · doi:10.1097/00006123-199704000-00027 · Cited by 83 · see citing works
Adult Hippocampal Neurogenesis in Parkinson’s Disease: Impact on Neuronal Survival and Plasticity
Regensburger, M., Prots, I., & Winner, B. (2014) · Neural Plasticity · doi:10.1155/2014/454696 · Cited by 85 · see citing works
Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease
Kim, M. ‐., Lee, J., Lee, W. Y., & Kim, S. (2004) · Phytotherapy Research · doi:10.1002/ptr.1486 · Cited by 84 · see citing works
Ghrelin: a link between ageing, metabolism and neurodegenerative disorders.
Stoyanova, I. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.026 · Cited by 80 · see citing works
Role of BDNF in Central Motor Structures and Motor Diseases
He, Y., Zhang, X., Yung, W., Zhu, J., & Wang, J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8466-y · Cited by 81 · see citing works
Matarredona, E. R., Santiago, M., Venero, J. L., Cano, J., & Machado, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00056.x · Cited by 81 · see citing works
Blaha, G. R., Raghupathi, R., Saatman, K. E., & McIntosh, T. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00214-1 · Cited by 80 · see citing works
Baydyuk, M., Nguyen, M. T., & Xu, B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.018 · Cited by 80 · see citing works
Physical Exercise-Induced Myokines in Neurodegenerative Diseases
Lee, B., Shin, M., Park, Y., Won, S.-Y., & Cho, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115795 · Cited by 79 · see citing works
Lü, X., & Hagg, T. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971124)388:3 · Cited by 79 · see citing works
Xiao, M.-F., Xu, J.-C., Tereshchenko, Y., Novak, D., Schachner, M., & KLEENE, R. B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4860-09.2009 · Cited by 78 · see citing works
Visanji, N. P., Orsi, A., Johnston, T. H., Howson, P. A., Dixon, K., Callizot, N., Brotchie, J. M., & Rees, D. D. (2008) · The FASEB Journal · doi:10.1096/fj.07-095398 · Cited by 78 · see citing works
Genetically engineered human neural stem cells for brain repair in neurological diseases.
Kim, S. (2007) · Brain & development (Tokyo. 1979) · doi:10.1016/j.braindev.2006.07.012 · Cited by 92 · see citing works
Halbach, O. V. B. U., Minichiello, L., & Unsicker, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-3845fje · Cited by 77 · see citing works
Mangano, E. N., Peters, S., Litteljohn, D., So, R., Bethune, C., Bobyn, J., Clarke, M., & Hayley, S. P. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.02.011 · Cited by 75 · see citing works
Hernandez-Chan, N. G., Bannon, M. J., Orozco-Barrios, C. E., Escobedo, L., Zamudio, S., De la Cruz, F., Gongora-Alfaro, J. L., Armendáriz-Borunda, J., Reyes-Corona, D., Espadas-Alvarez, A. J., et al. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0166-7 · Cited by 73 · see citing works
Ex vivo gene therapy for the treatment of neurological disorders
Gowing, G., Svendsen, S. P., & Svendsen, C. N. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.11.003 · Cited by 72 · see citing works
Localized cell and drug delivery for auditory prostheses
Hendricks, J. L., Chikar, J. A., Crumling, M. A., Raphael, Y., & Martin, D. C. (2008) · Hearing Research · doi:10.1016/j.heares.2008.06.003 · Cited by 71 · see citing works
Clark, J., Silvaggi, J. M., Kiselak, T., Zheng, K., Clore, E. L., Dai, Y., Bass, C. E., & Simon, D. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048925 · Cited by 70 · see citing works
Fukuhara, K., Ishikawa, K., Yasuda, S., Kishishita, Y., Kim, H.-K., Kakeda, T., Yamamoto, M., Norii, T., & Ishikawa, T. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9782-2 · Cited by 70 · see citing works
Intrastriatal and Intranigral Grafting of hNT Neurons in the 6-OHDA Rat Model of Parkinson's Disease
Baker, K. A., Hong, M. G. L., Sadi, D., & Méndez, I. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7337 · Cited by 70 · see citing works
Luellen, B. A., Bianco, L. E., Schneider, L., & Andrews, A. M. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00279.x · Cited by 68 · see citing works
Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons
Feng, L., Wang, C.-Y., Jiang, H., Oho, C., Mizuno, K., Dugich‐Djordjevic, M. M., & Lu, B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00015-7 · Cited by 66 · see citing works
Chmielarz, P., & Saarma, M. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00120-3 · Cited by 66 · see citing works
Thakker‐Varia, S., Behnke, J. A., Doobin, D. J., Dalal, V., Thakkar, K., Khadim, F., Wilson, E., Palmieri, A. J., Antila, H., Rantamäki, T., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.03.005 · Cited by 64 · see citing works
Berg, J., Roch, M., Altschüler, J., Winter, C., Schwerk, A. M. K., Kurtz, A., & Steiner, B. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9551-y · Cited by 66 · see citing works
Li, X., Dai, C., Chen, L., Zhou, W., Han, H., & Dong, Z. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12555 · Cited by 66 · see citing works
Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases
Gibrat, C., & Cicchetti, F. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.023 · Cited by 65 · see citing works
Angelucci, F., Piermaria, J., Gelfo, F., Shofany, J., Tramontano, M., Fiore, M., Caltagirone, C., & Peppe, A. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0322 · Cited by 64 · see citing works
Pröschel, C., Stripay, J. L., Shih, C., Munger, J. C., & Noble, M. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302878 · Cited by 64 · see citing works
Dou, S.-H., Cui, Y., Huang, S.-M., & Zhang, B. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.924155 · Cited by 63 · see citing works
Cell Transplantation for Parkinson's Disease: Present Status
Drucker-Colı́n, R., & Verdugo‐Díaz, L. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000022764.94760.3f · Cited by 62 · see citing works
Gardiner, J. C., Barton, D., Overall, R. L., & Marc, J. (2008) · The Neuroscientist · doi:10.1177/1073858408325269 · Cited by 62 · see citing works
Heckman, P. R. A., van Duinen, M. A., Bollen, E., Nishi, A., Wennogle, L. P., Blokland, A., & Prickaerts, J. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw030 · Cited by 60 · see citing works
Perreault, M. L., Fan, T., Alijaniaram, M., O’Dowd, B. F., & George, S. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033348 · Cited by 60 · see citing works
Mattson, M. P. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130335 · Cited by 58 · see citing works
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Kogure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01577-4 · Cited by 59 · see citing works
Shen, H., Marino, R. A. M., McDevitt, R. A., Bi, G.-H., Chen, K., Madeo, G., Lee, P.-T., Liang, Y., De Biase, L. M., Su, T.-P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800886115 · Cited by 58 · see citing works
Stahl, K., Mylonakou, M. N., Skare, Ø., Amiry-Moghaddam, M. R., & Torp, R. (2011) · Brain Research · doi:10.1016/j.brainres.2010.12.090 · Cited by 59 · see citing works
Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease
Yokoyama, H., Uchida, H., Kuroiwa, H., Kasahara, J., & Araki, T. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0424-0 · Cited by 57 · see citing works
Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness
Khalin, I., Kocherga, G., Bakar, M. A., & Alyautdin, R. N. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77480 · Cited by 57 · see citing works
- Authors
- Levivier, M., Przedborski, S., Bencsics, C., & Kang, U.
- Affiliations
- Columbia University (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1995-12-01
- Volume
- 15
- Issue
- 12
- Pages
- 7810-7820
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6577965
- OpenAlex
- W1590012920
- Cited by
- 274
- References
- 25
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 11 · 2019: 5 · 2018: 9 · 2017: 3 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 8 · 2012: 9
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Irving A. Hansen Memorial Foundation
- National Institutes of Health (5r29ns032080-05, 5k08ns001724-03)
- Parkinsonfonden
- Fogarty International Center
- National Institute of Neurological Disorders and Stroke (1-K08-NS01724-01, R29 NS32080)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, brain-derived neurotrophic factor, dopaminergic neuron loss, substantia nigra pars compacta, 6-hydroxydopamine, gene therapy, neuroprotection, nigrostriatal pathway, neurotrophic factors
- MeSH terms
- Animals, Autoradiography, Corpus Striatum, Dopamine, Fibroblasts, Genetic Engineering, Male, Nerve Degeneration, Nerve Growth Factors, Nerve Tissue Proteins, Neurons, Parkinson Disease, Rats, Inbred F344, Oxidopamine, Brain-Derived Neurotrophic Factor, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
